{
    "title": "Novartis scraps sale of assets including COVID-19 hopeful to India's Aurobindo",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8179191/Novartis-scraps-sale-assets-including-COVID-19-hopeful-Indias-Aurobindo.html",
    "date": "2020-04-02",
    "keywords": [
        "drug",
        "novartis",
        "narasimhan",
        "sandoz",
        "hydroxychloroquine",
        "transaction",
        "year",
        "price",
        "business",
        "thursday",
        "sale",
        "pill",
        "pharma",
        "ltd",
        "cancellation",
        "executive",
        "vas",
        "coronavirus",
        "treatment",
        "portfolio",
        "union",
        "proof",
        "collapse",
        "perspective",
        "trade",
        "approval",
        "aurobindo",
        "pressure",
        "profitability",
        "performance",
        "erosion",
        "growth",
        "skin",
        "rate",
        "dermatology",
        "company",
        "guidance",
        "part",
        "sandozs",
        "attention",
        "president",
        "miracle",
        "cure",
        "eu",
        "lack",
        "india",
        "way",
        "efficacy",
        "reporting",
        "john",
        "miller",
        "philip",
        "george",
        "bengaluru",
        "editing",
        "dasgupta",
        "michael"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}